Juan M. Maldonado

Cardiovascular outcomes trials with glucagon‐like peptide‐1 receptor agonists: A comparison of study designs, populations and results

C. Atisso, K. Pantalone, C. Hasenour, 2020, Diabetes, obesity & metabolism.

HbA1c Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial

D. Xavier, H. Gerstein, J. Basile, 2022, Diabetes care.

Gender differences in cardiovascular risk, treatment, and outcomes: a post hoc analysis from the REWIND trial.

H. Gerstein, L. Rydén, P. Rao-Melacini, 2023, Scandinavian cardiovascular journal : SCJ.